[HT-06] Hot Topics 06 New diagnostic and therapy strategies for PSP/CBD

[HT-06-5] Clinical spectrum of pathologically diagnosed CBD -Japanese multicenter study-

^○Ikuko Aiba¹, Mari Yoshida², Takayoshi Shimohata³, Koichi Wakabayashi⁴, Takashi Komori⁵, Yuko Saito⁶, Takeshi Ikeuchi⁷, Masato Hasegawa⁸, Aya M. Tokumaru⁹, Keita Sakurai¹⁰, Kenji Nakashima¹¹, J-VAC study group¹ (1.Department of Neurology, National Hospital Organization Higashinagoya National Hospital, Japan, 2.Institute for Medical Science of Aging, Aichi Medical University, 3.Department of Neurology, Gifu University Graduate School of Medicine, 4.Department of Neuropathology, Hirosaki University Graduate School of Medicine, 5.Department of Laboratory Medicine and Pathology, Tokyo Metropolitan Neurological Hospital, 6.Department of Neuropathology (the Brain Bank for Aging Research), 7.Niigata University, Brain Research Institute, Department of Molecular Genetics, 8.Department of Brain and Neurosciences Tokyo Metropolitan Institute of Medical Science, 9.Department of Diagnostic Radiology, Tokyo Metropolitan Medical Center of Gerontology, 10.Department of Radiology, National Center for Geriatrics and Gerontology, 11.National Hospital Organization Matsue Medical Center)

1987　　　　　 M.D. Nagoya University Graduate School of Medicine, Nagoya, Japan
1987–1988Internship, Kasugai City Hospital, Kasugai, Japan
1988–1993Staff Physician, Neurology, Kasugai City Hospital, Kasugai, Japan
1993–1994Staff Physician, Neurology, Nagoya University School of Medicine
1994–1997Staff Physician, Neurology, Higashinagoya National Hospital, Nagoya, Japan
1995 Ph.D. Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan
1997–present Chief Physician, Neurology, Higashinagoya National Hospital, Nagoya, Japan
2013–present Director of Rehabilitation, Higashinagoya National Hospital, Nagoya, Japan
2020–present Director of Clinical Research, Higashi Nagoya National Hospital, Nagoya, Japan